What is the typical BPC-157 dosage?

Published protocols describe 200–500 mcg, 1–2× daily, given subcutaneous (oral for gut). This is context from the literature, not a recommendation: a licensed provider sets the dose.

What are the side effects of BPC-157?

Risks noted for BPC-157 include injection-site reactions and limited human trial data. Tell your provider about your medications and conditions before starting.

What is the half-life of BPC-157?

The reported half-life is under 30 minutes (animal data). Onset is typically reported at 1–2 weeks.

How should BPC-157 be stored?

Refrigerated (2–8 °C); use within the pharmacy beyond-use date.

HEALING · PEPTIDE

What is BPC-157?

Medically reviewed by the G1 Peptides clinical team · Updated October 1, 2026

THE SHORT ANSWER

BPC-157 is a synthetic peptide of 15 amino acids, derived from a protein found in human gastric juice. It is studied for tissue repair, particularly tendon, ligament, muscle and gut healing. Almost all of the evidence comes from animal studies, and it is not approved by the FDA.

BPC-157 at a glance

Type: Peptide
Also known as: Body Protection Compound 157, PL 14736, Bepecin
Mechanism: Gastric pentadecapeptide; angiogenic and growth-factor signalling (VEGFR2, NO)
Status: Compounded (Rx)
Half-life: Under 30 minutes (animal data)
Route: Subcutaneous (oral for gut)
Dosing range in the literature: 200–500 mcg, 1–2× daily
Onset: 1–2 weeks
Storage: Refrigerated (2–8 °C); use within the pharmacy beyond-use date

How BPC-157 works

In animal and cell studies it promotes the growth of new blood vessels, increases the activity of growth-factor pathways, and affects nitric oxide signalling. These are thought to explain the faster healing seen in injured tissue in those models.

What BPC-157 is studied for

Tendon & ligament repair
Gut healing
Muscle recovery

Dozens of animal studies report faster healing of tendon, ligament, muscle and gut injuries. Human evidence is limited to a few small studies, so its benefit and long-term safety in people are not established.

Being studied for something is not proof that it works. Results in individuals vary.

BPC-157 dosing

Published protocols describe 200–500 mcg, 1–2× daily, once or twice daily, given subcutaneous (oral for gut). Onset is typically reported at 1–2 weeks.

These figures are context from the literature, not instructions. A licensed provider sets the dose and schedule for each patient.

BPC-157 dosage calculator →

BPC-157 side effects and risks

Injection-site reactions
Limited human trial data

Tell your provider about every medication and condition before starting, and report anything unexpected. See peptide side effects and safety and who should not use peptides.

Is BPC-157 FDA approved?

Not FDA-approved for any use. Prohibited in sport by the World Anti-Doping Agency.

Approval and trial status change. This page was last reviewed on October 1, 2026.

BPC-157 at G1 Peptides

G1 Peptides supplies BPC-157 as vials (5 mg, 10 mg) and in pens (Wolverine, Wolverine-S, GLOW, KLOW, X-23). Prescription products ship only after a licensed provider has reviewed the order.

Shop BPC-157 →

BPC-157 questions

What is BPC-157?: BPC-157 is a synthetic peptide of 15 amino acids, derived from a protein found in human gastric juice. It is studied for tissue repair, particularly tendon, ligament, muscle and gut healing. Almost all of the evidence comes from animal studies, and it is not approved by the FDA.
What is BPC-157 used for?: BPC-157 is studied for tendon & ligament repair, gut healing, and muscle recovery. Dozens of animal studies report faster healing of tendon, ligament, muscle and gut injuries. Human evidence is limited to a few small studies, so its benefit and long-term safety in people are not established.
How does BPC-157 work?: In animal and cell studies it promotes the growth of new blood vessels, increases the activity of growth-factor pathways, and affects nitric oxide signalling. These are thought to explain the faster healing seen in injured tissue in those models.
Is BPC-157 FDA approved?: Not FDA-approved for any use. Prohibited in sport by the World Anti-Doping Agency.
What is the typical BPC-157 dosage?: Published protocols describe 200–500 mcg, 1–2× daily, given subcutaneous (oral for gut). This is context from the literature, not a recommendation: a licensed provider sets the dose.
What are the side effects of BPC-157?: Risks noted for BPC-157 include injection-site reactions and limited human trial data. Tell your provider about your medications and conditions before starting.
What is the half-life of BPC-157?: The reported half-life is under 30 minutes (animal data). Onset is typically reported at 1–2 weeks.
How should BPC-157 be stored?: Refrigerated (2–8 °C); use within the pharmacy beyond-use date.

For educational purposes only, and not medical advice. These statements have not been evaluated by the FDA. Nothing on this page is intended to diagnose, treat, cure, or prevent any disease. Use any compound only under the guidance of a licensed provider.